244 related articles for article (PubMed ID: 23958398)
1. How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.
Morshed SA; Ma R; Latif R; Davies TF
J Autoimmun; 2013 Dec; 47():17-24. PubMed ID: 23958398
[TBL] [Abstract][Full Text] [Related]
2. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
3. Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.
Morshed SA; Ma R; Latif R; Davies TF
Sci Signal; 2018 Jan; 11(514):. PubMed ID: 29363585
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
5. Characterization of thyrotropin receptor antibody-induced signaling cascades.
Morshed SA; Latif R; Davies TF
Endocrinology; 2009 Jan; 150(1):519-29. PubMed ID: 18719020
[TBL] [Abstract][Full Text] [Related]
6. Rescue of thyroid cells from antibody induced cell death via induction of autophagy.
Morshed S; Latif R; Davies TF
J Autoimmun; 2022 Jan; 126():102746. PubMed ID: 34801870
[TBL] [Abstract][Full Text] [Related]
7. TSH receptor autoantibodies.
Michalek K; Morshed SA; Latif R; Davies TF
Autoimmun Rev; 2009 Dec; 9(2):113-6. PubMed ID: 19332151
[TBL] [Abstract][Full Text] [Related]
8. Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease.
Morshed S; Latif R; Davies TF
J Autoimmun; 2023 Apr; 136():103012. PubMed ID: 36898184
[TBL] [Abstract][Full Text] [Related]
9. Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival
Morshed SA; Ma R; Latif R; Davies TF
Thyroid; 2019 Jul; 29(7):993-1002. PubMed ID: 31025602
[No Abstract] [Full Text] [Related]
10. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
Neumann S; Eliseeva E; McCoy JG; Napolitano G; Giuliani C; Monaco F; Huang W; Gershengorn MC
J Clin Endocrinol Metab; 2011 Feb; 96(2):548-54. PubMed ID: 21123444
[TBL] [Abstract][Full Text] [Related]
11. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
Morshed SA; Ma R; Latif R; Davies TF
Thyroid; 2022 Apr; 32(4):429-439. PubMed ID: 34927457
[No Abstract] [Full Text] [Related]
13. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
14. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
15. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
[TBL] [Abstract][Full Text] [Related]
17. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
18. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
[TBL] [Abstract][Full Text] [Related]
19. Hormone- and antibody-mediated activation of the thyrotropin receptor.
Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
[TBL] [Abstract][Full Text] [Related]
20. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
